• 1
    Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398404.
  • 2
    Ford ES, Giles WH. Prevalence of the metabolic syndrome by blood pressure status: findings from two national surveys. Abstract presented at the International Society of Hypertension in Blacks Annual Meeting; July 1518, 2005; San Juan, Puerto Rico.
  • 3
    Bonow RO, Gheorghiade M. The diabetes epidemic: a national and global crisis. Am J Med. 2004;116(suppl 5A):2S10S.
  • 4
    Flegal KM, Carroll MS, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:17231727.
  • 5
    Hendley AA, Mushinski M. The Social Security system: benefit differences among racial/ethnic groups. Stat Bull Metrop Insur Co. 2000;81:916.
  • 6
    Park Y-W, Zhu S, Palniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163:427436.
  • 7
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356359.
  • 8
    Staessen JA, Li Y, Thijs L, et al. Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res. 2005;28:385407.
  • 9
    Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations in the Anglo-Scandinavian Cardiac Outcomes Trials—Lipid Lowering Arm (ASCOT-LLA): a multicenter randomized trial. Lancet. 2003;361:11491158.
  • 10
    Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383393.
  • 11
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 19882000. JAMA. 2003;290:199206.
  • 12
    Ford ES, Mokdad A, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107:21852189.
  • 13
    Hall WD, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997;313:195209.
  • 14
    Blewett LA, Good MB, Call KT, et al. Monitoring the uninsured: a state policy perspective. J Health Polit Policy Law. 2004;29:107145.
  • 15
    Bestermann WH, Lackland DT, Riehle JE, et al. A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004;97:932938.
  • 16
    Krakoff LR. The ASH specialists program: a progress report. American Society of Hypertension. Am J Hypertens. 2002;15:577579.
  • 17
    Egan BM, Lackland DT, Basile JN. American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002;15:372379.
  • 18
    Ofili E, Igho-Pemu P, Quarshie A, et al. Community Physicians Network©: a practice-based consortium to eliminate healthcare disparities. The ABC Digest of Urban Cardiology. 2004;30:2526.
  • 19
    Ofili E, Igho-Pemu P, Lapu-Bula R, et al. The Community Physicians' Network (CPN): an academic-community partnership to eliminate healthcare disparities. Ethn Dis. 2005;15(4 suppl 5):S5-125S5-127.
  • 20
    Igho-Pemu P, Quarshie A, Oduwole A, et al. Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education. Ethn Dis. 2005;15(4 suppl 5):S5120S5123.
  • 21
    Ofili EO, Igho-Pemu P, Reed J, et al. The Healthy Georgia diabetes and obesity initiative. The ABC Digest of Urban Cardiology. 2005;31:11.
  • 22
    Egan BM, Hendrix K, Okonofua EC, et al. Ethnicity and cardiovascular risk factor treatment and control in primary care [abstract]. Ethn Dis. 2004;14(suppl 2):S2S4.
  • 23
    Hendrix KH, Nida AN, Egan BM. Geographic distribution of ethnic and age-related differences in treatment and control of hypertensive dyslipidemic patients in primary care [abstract]. Ethn Dis. 2004;14:S2S47.
  • 24
    Sheats N, Lin Y, Zhao W, et al. Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically underserved patients. Ethn Dis. 2005;15:2532.
  • 25
    Riehle JE, Lackland DT, Okonofua EC, et al. Ethnic differences in treatment and control of hypertension in patients with diabetes. J Clin Hypertens (Greenwich). 2005;7:445454.
  • 26
    Rehman SU, Hutchison FN, Hendrix K, et al. Comparison of ethnic differences in blood pressure control at VA and non-VA sites. Arch Intern Med. 2005;165:10411047.
  • 27
    Okonofua EC, Simpson K, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345351.
  • 28
    Egan BM, Basile JN. Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the Healthy People 2010 Report? J Investig Med. 2003;51:373385.
  • 29
    Perry HM, Roccella EJ. Conference report on stroke mortality in the southeastern United States. Hypertension. 1998;31:12061215.
  • 30
    American Heart Association. Heart Disease and Stroke Statistics—2001 Update. Dallas, TX: American Heart Association; 2001.